Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.
Causaly has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in July 2023.
Causaly's investors include Index Ventures, ICONIQ Growth, Marathon Venture Capital, Pentech Ventures, Visionaries Club.
Causaly is headquartered in London, United Kingdom.
Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.
Causaly is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Causaly — Funding & Investors." VCBacked, July 13, 2023, https://www.vcbacked.co/company/causaly. Accessed September 13, 2026.
VCBacked. (2023). Causaly — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/causaly
{{cite web |title=Causaly — Funding & Investors |url=https://www.vcbacked.co/company/causaly |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated